BioSpace News Archive

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced the recent formation of a subsidiary, Volition Veterinary Diagnostics Development LLC (“Volition Veterinary”), and the appointment of animal health expert Nathan Dewsbury as its Chief Executive Officer

NetDirector, a cloud-based data exchange and integration platform, has once again diversified their Radiology automation options by adding a new service that supports enterprise level PDF to DICOM (Digital Imaging and Communications in Medicine) conversion in a real-time fashion (specifically, DICOM Encapsulated PDF).

Physician owners will benefit from an integrated platform for medical records, practice management and revenue cycle.

R3 Stem Cell, LLC (R3) announced that they will be offering a 2 Day Stem Cell Training Course in Mexico

Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today it has developed a method to quantify the active ingredients of Propanc’s lead product candidate, PRP, in preparation for the company’s First-In-Human (“FIH”) study, planned for early 2020.

The global ear tubes devices market is expected to post a CAGR of more than 2% during the period 2019-2023, according to the latest market research report by Technavio.

NorthStar Anesthesia (“NorthStar” or the “Company”), one of the country’s leading anesthesia care providers, today announced a number of strategic senior leadership appointments designed to enhance its organizational structure and reporting lines, positioning the Company for its next phase of growth through expanded operational capabilities.

B.C.-based cannabis producer shares quarterly sales and production numbers exceeding projections

Pivotal study to inform framework for how to use RWE to support regulatory and reimbursement decisions

Landmark Study of Over 100,000 Diabetes Patient Visits Published in the Journal Diabetes Technology and Therapeutics Validates the Prowess of the EyeArt AI System for Diabetic Retinopathy Screening